HAVN Life Sciences Inc. (HAVLF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Jul 21, 2026
HAVN Life Sciences Market Cap
HAVN Life Sciences has a market cap or net worth of $29 as of August 14, 2026. Its market cap has decreased by -99.95% in one year.
Market Cap
29.00
Enterprise Value
n/a
Revenue
440.11K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since October 22, 2020, HAVN Life Sciences's market cap has decreased from 46.06M to 29.00, a decrease of -100.00%. That is a compound annual growth rate of -91.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 29.00 | -99.90% |
| Dec 31, 2024 | 28.65K | -98.33% |
| Dec 29, 2023 | 1.72M | 107.74% |
| Dec 30, 2022 | 827.36K | -95.13% |
| Dec 31, 2021 | 16.97M | -71.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoSec Medical | 60.00 |
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |
| Mymetics | 46.00 |
| Claritas Pharmaceuticals | 38.00 |
| Intellipharmaceutics International | 33.00 |